Squamous cell carcinoma of the head and neck Trials in Detroit, United States
Conditions / Squamous cell carcinoma of the head and neck / Detroit, United States
Squamous cell carcinoma of the head and neck has been the subject of sustained clinical investigation across multiple research sites.
16 total trials for this combination
Showing top 10 of 16 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT02376699 | Safety Study of SEA-CD40 in Cancer Patients | TERMINATED | PHASE1 |
| NCT05208762 | A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors | RECRUITING | PHASE1 |
| NCT02452424 | A Combination Clinical Study of PLX3397 and Pembrolizumab To Treat Advanced Melanoma and Other Solid Tumors | TERMINATED | PHASE1/PHASE2 |
| NCT03849469 | A Study of XmAb®22841 Monotherapy & in Combination w/ Pembrolizumab in Subjects w/ Selected Advanced Solid Tumors | COMPLETED | PHASE1 |
| NCT05783622 | Study of JANX008 in Subjects With Advanced or Metastatic Solid Tumor Malignancies | RECRUITING | PHASE1 |
| NCT04459715 | A Study of Xevinapant (Debio 1143) in Combination With Platinum-Based Chemotherapy and Standard Fractionation Intensity-Modulated Radiotherapy in Participants With Locally Advanced Squamous Cell Carcinoma of the Head and Neck, Suitable for Definitive Chemoradiotherapy (TrilynX) | TERMINATED | PHASE3 |
| NCT03645928 | Study of Autologous Tumor Infiltrating Lymphocytes in Patients With Solid Tumors | RECRUITING | PHASE2 |
| NCT02636036 | Phase I Study of Enadenotucirev and PD-1 Inhibitor in Subjects With Metastatic or Advanced Epithelial Tumors | COMPLETED | PHASE1 |
| NCT03517488 | A Study of XmAb®20717 in Subjects With Selected Advanced Solid Tumors | COMPLETED | PHASE1 |
| NCT02952586 | Study To Compare Avelumab In Combination With Standard of Care Chemoradiotherapy (SoC CRT) Versus SoC CRT for Definitive Treatment In Patients With Locally Advanced Squamous Cell Carcinoma Of The Head And Neck (JAVELIN HEAD AND NECK 100) | TERMINATED | PHASE3 |